FDA Approves Xembify for Primary Immunodeficiencies

in health •  5 years ago 

The US Food and Drug Administration (FDA) has approved Grifols’ first immunoglobulin Xembify®, 20% solution for the treatment of primary immunodeficiencies in patients as young as 2 years old.
https://blog.genexi.ru/news/FDA-Approves-Xembify-for-Primary-Immunodeficiencies-en

health pharma immunodeficiency
5 years ago by

Downvoting a post can decrease pending rewards and make it less visible. Common reasons:

  • Disagreement on rewards
  • Fraud or plagiarism
  • Hate speech or trolling
  • Miscategorized content or spam

Submit
$0.00
    1 vote
    0
    Authors get paid when people like you upvote their post.
    If you enjoyed what you read here, create your account today and start earning FREE STEEM!